From EST to IHC: Human antibody pipeline for target research

Journal of Immunological Methods

Volumn 275, Issue 1-2, 2003, Pages 203-212

  Frisch, Christian ^a   Brocks, Bodo ^a   Ostendorp, Ralf ^a   Hoess, Adolf ^a,b   Von Rüden, Thomas ^a   Kretzschmar, Titus ^a  

^a MORPHOSYS AG   (Germany)

^b CARL ZEISS SMT AG   (Germany)

Author keywords

Expressed sequence tags; Fab antibody fragments; Functional genomics; Inclusion bodies; Phage display; Recombinant protein expression; Single chain Fv antibody fragments

Indexed keywords

ANTIBODY; HYBRID PROTEIN;

ANIMAL CELL; ARTICLE; BACTERIOPHAGE; CARBOXY TERMINAL SEQUENCE; CELL INCLUSION; CONTROLLED STUDY; ESCHERICHIA COLI; EXPRESSED SEQUENCE TAG; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SYNTHESIS;

ESCHERICHIA COLI;

EID: 0037377029     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(03)00011-5     Document Type: Article

References (26)

1. Adams M.D., Kerlavage A.R., Fleischmann R.D., Fuldner R.A., Bult C.J., Lee N.H., Kirkness E.F., Weinstock K.G., Gocayne J.D., White O. Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature. 377(6547 Suppl.):1995;3.
2. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Sedman J.G., Smith J.A., Struhl K. Current Protocols in Molecular Biology. 1998;Wiley, New York.
3. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 256:1981;1604.
4. Forrer P., Jaussi R. High-level expression of soluble heterologous proteins in the cytoplasm of Escherichia coli by fusion to the bacteriophage Lambda head protein D. Gene. 224:1998;45.
5. Freund C., Ross A., Guth B., Plückthun A., Holak T.A. Characterization of the linker peptide of the single-chain Fv fragment of an antibody by NMR spectroscopy. FEBS Lett. 320:1993;97.
6. Gill S.G., von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182:1989;319.
7. Hannig G., Makrides S.C. Strategies for optimizing heterologous protein expression in Escherichia coli. Trends Biotechnol. 16:1998;54.
8. Holliger P., Riechmann L. A conserved infection pathway for filamentous bacteriophages is suggested by the structure of the membrane penetration domain of the minor coat protein g3p from phage fd. Structure. 5:1997;265.
9. Jung S., Arndt K.M., Müller K.M., Plückthun A. Selectively infective phage (SIP) technology: scope and limitations. J. Immunol. Methods. 231:1999;93.
10. Knappik A., Ge L., Honegger A., Pack P., Fischer M., Wellnhofer G., Hoess A., Wölle J., Plückthun A., Virnekäs B. Fully synthetic Human Combinatorial Antibody Libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J. Mol. Biol. 296:2000;57.
11. Krebber C., Spada S., Desplancq D., Plückthun A. Co-selection of cognate antibody-antigen pairs by selectively-infective phages. FEBS Lett. 377:1995;227.
12. Krebber C., Spada S., Desplancq D., Krebber A., Ge L., Plückthun A. Selectively-infective phage (SIP): a mechanistic dissection of a novel in vivo selection for protein-ligand interactions. J. Mol. Biol. 268:1997;607.
13. Krebs B., Rauchenberger R., Reiffert S., Rothe C., Tesar M., Thomassen E., Cao M., Dreier T., Fischer D., Höß A., Inge L., Knappik A., Marget M., Pack P., Meng X., Schier R., Söhlemann P., Winter J., Wölle J., Kretzschmar T. High-throughput generation and engineering of recombinant human antibodies. J. Immunol. Methods. 254:2001;67.
14. Lubkowski J., Hennecke F., Plückthun A., Wlodawer A. The structural basis of phage display elucidated by the crystal structure of the N-terminal domains of g3p. Nat. Struct. Biol. 5:1998;140.
15. Mössner E., Koch H., Plückthun A. Fast selection of antibodies without antigen purification: adaptation of the protein fragment complementation assay to select antigen-antibody pairs. J. Mol. Biol. 308:2001;115.
16. Murby M., Uhlen M., Stahl S. Upstream strategies to minimize proteolytic degradation upon recombinant production in Escherichia coli. Protein Expr. Purif. 7:1996;129.
17. Nagy Z.A., Hubner B., Löhning C., Rauchenberger R., Reiffert S., Thomassen-Wolf E., Zahn S., Leyer S., Schier E.M., Zahradnik A., Brunner C., Stanglmaier M., Anderson S., Dunn M., Hallek M., Kretzschmar T., Tesar M. Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells. Nat. Med. 8:2002;801.
18. Pelletier J.N., Campbell-Valois F.X., Michnick S.W. Oligomerization domain-directed reassembly of active dihydrofolate reductase from rationally designed fragments. Proc. Natl. Acad. Sci. U. S. A. 95:1998;12414.
19. Persic L., Horn I.R., Rybak S., Cattaneo A., Hoogenboom H.R., Bradbury A. Single-chain variable fragments selected on the 57-76 p21Ras neutralising epitope from phage antibody libraries recognise the parental protein. FEBS Lett. 443:1999;112.
20. Plückthun A., Pack P. New protein engineering approaches to multivalent and bispecific antibody fragments. Immunotechnology. 3:1997;83.
21. Schoner B.E., Belagaje R.M., Schoner R.G. Enhanced translational efficiency with two-cistron expression system. Methods Enzymol. 185:1990;94.
22. Schulze-Gahmen U., Rini J.M., Wilson I.A. Detailed analysis of the free and bound conformations of an antibody: X-ray structures of Fab 17/9 and three different Fab-peptide complexes. J. Mol. Biol. 234:1993;1098.
23. Siegel R.W., Allen B., Pavlik P., Marks J.D., Bradbury A. Mass spectral analysis of a protein complex using single-chain antibodies selected on a peptide target: applications to functional genomics. J. Mol. Biol. 302:2000;285.
24. Studier F.W., Rosenberg A.H., Dunn J.J., Dubendorff J.W. Use of T7 RNA polymerase to direct the expression of cloned genes. Methods Enzymol. 185:1990;60.
25. Sykes K.F., Johnston S.A. Linear expression elements: a rapid, in vivo, method to screen for gene functions. Nat. Biotechnol. 17:1999;355.
26. Venter, J.C., Adams, M.D., 1993. International patent application WO 93/00353.